bioRxivGenomicsPreprint
Unique amino acid substitution in RBD region of SARS-CoV-2 Omicron XAY.2
Abstract
We attempted to explain the rare mutation at the receptor binding domain of the spike protein in the XAY.2 variant of SARS-CoV-2 from the perspective of hydrophobic interactions. We propose that decreasing hydrophobicity at position 446 and 486 of the RBD region of the spike protein might affect the infectivity of SARS-CoV-2. We also estimated the probable mutations at the 446 and 486 position the virus may acquire, leading to a decreased hydrophobicity.
- organism: virus
- assay: proteomics
- research focus: protein structure prediction
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Effect of Delta and Omicron mutations on the RBD-SD1 do-main of the Spike protein in SARS-CoV-2 and the Omicron mutations on RBD-ACE2 interface complex
W.-Y. Ching, P. Adhikari, … R. Podgornik·bioRxiv·Jul 28, 2022
- The high infectivity of the SARS-CoV-2 Omicron variant is associated with an exclusive S477N spike receptor-binding domain mutation
Jadson C. Santos, Elvira Regina Tamarozzi, … Geraldo Aleixo Silva Passos·bioRxiv·Sep 11, 2023
- Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant
Arijit Samanta, Syed Sahajada Mahafujul Alam, … Mehboob Hoque·bioRxiv·Dec 23, 2021
- Mutations of Omicron variant at the interface of the receptor domain motif and human angiotensin-converting enzyme-2
P. Adhikari, B. Jawad, … W.-Y. Ching·bioRxiv·Feb 4, 2022
- Binding Interactions between RBD of Spike-Protein and Human ACE2 in Omicron variant
B. Jawad, P. Adhikari, … W.-Y. Ching·bioRxiv·Feb 10, 2022
- Omicron (BA.1) and Sub-Variants (BA.1, BA.2 and BA.3) of SARS-CoV-2 Spike Infectivity and Pathogenicity: A Comparative Sequence and Structural-based Computational Assessment
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam·Journal of Medical VirologyPeer-reviewed·Jun 9, 2022